Multifaceted Associations Between Walking Performance, Physical Fitness, Extremity Function, Health Status, and Depression in Individuals with COPD

Overview

Journal Ann Med

Publisher Informa Healthcare

Specialty General Medicine

Date 2024 Apr 9

PMID 38590164

Authors

Monira I Aldhahi

Baian A Baattaiah

Mutasim D Alharbi

Mansour Alotaibi

Rakan Nazer

Ali Albarrati

Affiliations

Soon will be listed here.

Abstract

Background/objective(s): Chronic obstructive pulmonary disease (COPD) can precipitate a deterioration of an individual's physical performance and overall health. Evidence suggests that, along with pulmonary functions, several other factors are related to the significant impairment of walking performance in individuals with COPD. This study compared the depressive symptoms, health status, upper and lower extremity functions, and peak oxygen uptake (VO) in a group of individuals with COPD based on walking performance using a cutoff distance of 350 m in the six-minute walking test (6MWT). The study also investigated the associations between these factors and walking performance.

Materials And Methods: Participants performed the 6MWT according to the guidelines and were classified into high (>350 m; = 40) or low (<350 m; = 30) walking performance groups according to distance. The forced expiratory volume (FEV1), forced vital capacity (FVC), and FEV1/FVC ratio were recorded. Participants completed the Patient Health Questionnaire-9 (PHQ-9), St. George's Respiratory Questionnaire (SGRQ), and the Upper and Lower Extremity Functional Index (UEFI/LEFI). Predicted VO was measured using the Duke Activity Status Index (DASI).

Results: Seventy participants with a mean age of 63 ± 11 years (20% female) were enrolled in this study. Patients with high walking performance demonstrated significantly better health status than those with low walking performance (SGRQ: 49 ± 25 vs. 56 ± 21, = 0.03). Participants with low walking performance had lower predicted VO compared to their higher performing counterparts ( = 0.002). The overall model was significant (F(8, 61) = 7.48, = 0.0006), with PHQ-9, SGRQ, UEFI/LEFI, VO, and FEV1/FVC explaining approximately 49.5% of the variance in the 6MWT distance.

Conclusion: This study shed light on the association of depressive symptoms, health status, extremity function, and VO with walking performance, providing valuable insights that may impact the management and care of individuals with COPD.

Citing Articles

Associations of the Charlson comorbidity index with depression and mortality among the U.S. adults.

Wang Y, Xue C, Ma C, Liu A Front Public Health. 2024; 12:1404270.

PMID: 39664531 PMC: 11632622. DOI: 10.3389/fpubh.2024.1404270.

References

AlHadi A, Alateeq D, Al-Sharif E, Bawazeer H, Alanazi H, Alshomrani A . An arabic translation, reliability, and validation of Patient Health Questionnaire in a Saudi sample. Ann Gen Psychiatry. 2017; 16:32. PMC: 5585978. DOI: 10.1186/s12991-017-0155-1. View

Wada J, Borges-Santos E, Cano Porras D, Paisani D, Cukier A, Lunardi A . Effects of aerobic training combined with respiratory muscle stretching on the functional exercise capacity and thoracoabdominal kinematics in patients with COPD: a randomized and controlled trial. Int J Chron Obstruct Pulmon Dis. 2016; 11:2691-2700. PMC: 5094573. DOI: 10.2147/COPD.S114548. View

Wu M, Teng C, Kuo T, Huang W, Wen C . A Pervasive Pulmonary Function Estimation System with Six-Minute Walking Test. Biosensors (Basel). 2022; 12(10). PMC: 9599376. DOI: 10.3390/bios12100824. View

McDougall J, Wright V, Rosenbaum P . The ICF model of functioning and disability: incorporating quality of life and human development. Dev Neurorehabil. 2010; 13(3):204-11. DOI: 10.3109/17518421003620525. View

Hill K, Geist R, Goldstein R, Lacasse Y . Anxiety and depression in end-stage COPD. Eur Respir J. 2008; 31(3):667-77. DOI: 10.1183/09031936.00125707. View

Agusti A, Celli B, Criner G, Halpin D, Anzueto A, Barnes P . Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Am J Respir Crit Care Med. 2023; 207(7):819-837. PMC: 10111975. DOI: 10.1164/rccm.202301-0106PP. View

Lange P, Ahmed E, Lahmar Z, Martinez F, Bourdin A . Natural history and mechanisms of COPD. Respirology. 2021; 26(4):298-321. DOI: 10.1111/resp.14007. View

Aldhahi M, Baattaiah B, Nazer R, Albarrati A . Impact of Psychological Factors on Functional Performance among Patients with Chronic Obstructive Pulmonary Disease. Int J Environ Res Public Health. 2023; 20(2). PMC: 9859091. DOI: 10.3390/ijerph20021285. View

ODonnell D, Webb K . The major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol (1985). 2008; 105(2):753-5. DOI: 10.1152/japplphysiol.90336.2008b. View

10.

von Leupoldt A, Taube K, Lehmann K, Fritzsche A, Magnussen H . The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest. 2011; 140(3):730-736. DOI: 10.1378/chest.10-2917. View

11.

Spruit M, Watkins M, Edwards L, Vestbo J, Calverley P, Pinto-Plata V . Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med. 2010; 104(6):849-57. DOI: 10.1016/j.rmed.2009.12.007. View

12.

Graham B, Steenbruggen I, Miller M, Barjaktarevic I, Cooper B, Hall G . Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019; 200(8):e70-e88. PMC: 6794117. DOI: 10.1164/rccm.201908-1590ST. View

13.

Aljathlani M, Alshammari M, Alsuwaygh M, Al-Mutairi M, Aljassir F, Bindawas S . Cross-cultural adaptation and validation of the Arabic version of the upper extremity functional index. Disabil Rehabil. 2021; 44(19):5656-5662. DOI: 10.1080/09638288.2021.1947396. View

14.

Ehsani H, Mohler M, Golden T, Toosizadeh N . Upper-extremity function prospectively predicts adverse discharge and all-cause COPD readmissions: a pilot study. Int J Chron Obstruct Pulmon Dis. 2018; 14:39-49. PMC: 6305140. DOI: 10.2147/COPD.S182802. View

15.

Marin J, Carrizo S, Gascon M, Sanchez A, Gallego B, Celli B . Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 163(6):1395-9. DOI: 10.1164/ajrccm.163.6.2003172. View

16.

Wedzicha J, Seemungal T . COPD exacerbations: defining their cause and prevention. Lancet. 2007; 370(9589):786-96. PMC: 7134993. DOI: 10.1016/S0140-6736(07)61382-8. View

17.

Louvaris Z, Kortianou E, Spetsioti S, Vasilopoulou M, Nasis I, Asimakos A . Intensity of daily physical activity is associated with central hemodynamic and leg muscle oxygen availability in COPD. J Appl Physiol (1985). 2013; 115(6):794-802. DOI: 10.1152/japplphysiol.00379.2013. View

18.

Hynninen K, Breitve M, Wiborg A, Pallesen S, Nordhus I . Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res. 2005; 59(6):429-43. DOI: 10.1016/j.jpsychores.2005.04.007. View

19.

Pan L, Guo Y, Yan J, Zhang W, Sun J, Li B . Does upper extremity exercise improve dyspnea in patients with COPD? A meta-analysis. Respir Med. 2012; 106(11):1517-25. DOI: 10.1016/j.rmed.2012.08.002. View

20.

Sanchez-Martinez M, Bernabeu-Mora R, Martinez-Gonzalez M, Gacto-Sanchez M, Martin San Agustin R, Medina-Mirapeix F . Stability and Predictors of Poor 6-min Walking Test Performance over 2 Years in Patients with COPD. J Clin Med. 2020; 9(4). PMC: 7231211. DOI: 10.3390/jcm9041155. View